The early innings of the obesity landscape is starting to take shape, and it seems to be forming similar patterns...
Read NowModular Medical (MODD) announced the 510(k) submission of their MODD1 insulin pump to the FDA last week. On average, the FDA takes approximately...
PremiumLong Ideas - With a broad 12-asset pipeline, Immunomedics (IMMU), at first glance, lacks focus. But a closer look reveals a diverse development program supported by solid clinical … Continue Reading
Read nowMost Popular - It’s been a great week for Medicinova (MNOV) shareholders, who saw their holdings climb as much as 80% with the announcement that the company’s lead … Continue Reading
Read nowInsights - Optimer Pharma (OPTR) announced that along with the ousting of upper level management and appointment of an interim CEO, it’s putting the company up for … Continue Reading
Read nowLong Ideas - The Bears may focus on the pushes and pulls around Questcor Pharmaceuticals’ (QCOR) 4Q 2012 earnings results, but the bottom line is, the earnings results … Continue Reading
Read nowLong Ideas - Endo Pharmaceuticals (ENDP) named its new CEO Monday morning, Rajiv De Silva, who was formerly President and COO of Valeant Pharmaceuticals (VRX). In a January … Continue Reading
Read nowMost Popular - SciClone Pharmaceuticals (SCLN) is restating its financials from 2011 and the first nine months of 2012, an announcement that causes additional concern for this U.S.-based, … Continue Reading
Read nowMost Popular - The Home Health Services industry remains under pressure due to regulatory scrutiny and looming reimbursement cuts. As we have written in the past, Amedisys, Inc. … Continue Reading
Read now
